SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as escalating Middle East tensions, including the Strait of Hormuz disruption and production cuts, initially sent oil prices soaring. However, immediate market conversation has shifted to the G7 and IEA's reported announcement of a massive strategic oil reserve release, prompting debate on whether the rally will continue or if a sharp downturn is imminent.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending after resolving its legal dispute with Novo Nordisk and partnering to offer FDA-approved GLP-1 weight-loss medications on its platform, eliminating a significant bear thesis. This development has ignited strong bullish sentiment, with the community actively discussing a potential short squeeze due to high short interest and anticipating analyst upgrades.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to renewed short squeeze speculation and anticipation surrounding upcoming earnings, with community discussion highlighting favorable technical chart patterns and the company's robust cash position amid its ongoing business transformation.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is gaining attention following updates indicating clinical improvements for its epetraborole program and plans to discuss re-initiating a Phase 3 study, reversing a prior setback that caused a significant drop. This, combined with new strategic collaborations, financing, and recent insider buying, has sparked a community discussion between optimistic bulls targeting substantial gains and cautious observers anticipating further volatility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as investors grapple with its latest earnings, revealing robust park performance and the appointment of Josh D'Amaro as the new CEO, sparking divided community discussion on the company's strategic direction, content output, and long-term valuation.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is experiencing a significant surge with high volume, fueled by aggressive short covering and institutional buying, propelling it past a key resistance level. The community is actively debating a potential short squeeze and anticipating international approvals for its pioneering TIL therapy, believing the stock is fundamentally undervalued.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant attention as bullish investors react to the CEO's recent remarks hinting at "curative outcomes" for its lead AML immunotherapy, GPS, fueling high conviction about its potential and sparking discussions of a substantial short squeeze.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals is a trending topic following the successful submission of its RapidSX technology's Phase 1 report to the U.S. Department of War, showcasing superior efficiency in rare earth separation. The community is actively discussing impending government investments, potential critical mineral price floors, and Ucore's pivotal role in establishing a secure, non-Chinese supply chain amid escalating global geopolitical focus on vital resources.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending due to heightened global geopolitical tensions and rising oil prices, prompting community discussion around an imminent market volatility spike and a potential correction. Many are positioning for upside in the VIX (fear gauge) as a hedge, while others caution against the leveraged ETF's inherent decay.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil ($SCO) is a hot topic as the community actively positions for a significant downturn in crude prices. Many anticipate a reversal from recent highs, believing the surge linked to geopolitical concerns and supply worries may be overextended, with discussions focused on potential reserve releases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Deutsche Bank Aktiengesellschaft Cuts Oracle (NYSE:ORCL) Price Target to $300.00

Deutsche Bank Aktiengesellschaft dropped their price target on Oracle from $375.00 to $300.00 and set a "buy" rating on the stock in a research note on Monday...

Scotiabank Lowers Oracle (NYSE:ORCL) Price Target to $215.00

Scotiabank dropped their price target on Oracle from $220.00 to $215.00 and set a "sector outperform" rating for the company in a research note on Monday...

Oracle (NYSE:ORCL) Price Target Lowered to $230.00 at Barclays

Barclays reduced their price objective on Oracle from $310.00 to $230.00 and set an "overweight" rating on the stock in a research note on Monday...

Key Events This Week: CPI, PCE, ADP, Durable Goods And More

Key Events This Week: CPI, PCE, ADP, Durable Goods And More With the Fed in their self-imposed blackout period, the economic data will get a chance to do the talking ahead of the March 18th FOMC...

Billionaire Ray Dalio delivers blunt message on gold

Billionaire Ray Dalio feels the debate between gold and bitcoin has a clear winner.In his opinion, the precious metal remains the ultimate safe haven, while bitcoin mostly behaves like a risk asset...

Oracle's AI Push: A Potential Catalyst for Q3 Earnings Growth?

ORCL heads into fiscal Q3 earnings with AI launches, soaring cloud momentum and expanding OCI capacity that may help fuel revenue and EPS growth.

Pre-Markets Down as Middle East Tensions Remain

The ongoing war in Iran is now in its second week with no signs of a peace deal.

Here are Monday's biggest analyst calls: Nvidia, Apple, Netflix, Oracle, Micron, Starbucks, Jefferies & more

Here are the biggest calls on Wall Street on Monday...

Vestcor Inc Sells 12,690 Shares of Oracle Corporation $ORCL

Vestcor Inc lessened its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 19.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 52,764...

Sienna Gestion Buys 7,439 Shares of Oracle Corporation $ORCL

Sienna Gestion grew its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 18.4% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned...

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $ORCL earnings Tuesday?

Stocktwits

Stocktwits Polls

Traders are reacting to conflicting reports and denials regarding Oracle's flagship Texas AI data center project and potential new tenant interests.

High anticipation for Oracle's upcoming Q3 earnings is driving intense debate and speculative trading on potential price swings.

Many users are convinced that recent negative news and price drops are orchestrated 'FUD' from short sellers aiming for manipulation.

Discussions focus on Oracle's long-term potential in the burgeoning AI cloud infrastructure market amidst evolving partnership dynamics.

Current Price	$149.98
Prev Close	$152.96
Open	$150.85
Dividend Yield	1.03%
50-Day Moving Average	$170.62
Beta	1.44
Avg. Volume	30.46M
PE Ratio	28.75

52-Week High	$345.72
52-Week Low	$118.86
Market Capitalization	$439.62B
EPS (Annual)	$4.34
Price to Book	14.67
Revenue Per Employee	$354,314.82

ORCL
Oracle Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORCL News

ORCLOracle Corp.